Literature DB >> 11117542

Pick's disease is associated with mutations in the tau gene.

S Pickering-Brown1, M Baker, S H Yen, W K Liu, M Hasegawa, N Cairns, P L Lantos, M Rossor, T Iwatsubo, Y Davies, D Allsop, R Furlong, F Owen, J Hardy, D Mann, M Hutton.   

Abstract

Recently, mutations within the tau gene have been associated with some familial forms of frontotemporal dementia. To investigate whether tau gene mutations are also associated with Pick's disease, we analyzed the tau gene in 30 cases of pathologically confirmed Pick's disease. Two coding mutations were identified in separate cases of Pick's disease. A glycine-to-arginine mutation at codon 389 was detected in 1 case and a lysine-to-threonine mutation at codon 257 was identified in another. Analysis of dephosphorylated tau from the brain of the patient with the codon 389 mutation revealed a prominent band representing tau, with four microtubule-binding domains and no amino terminal inserts. This is in contrast to Pick's disease without any tau gene mutations, which consist of tau with mainly three microtubule-binding domains and only a trace of tau, with four microtubule-binding domains. Functional analysis of tau with these two mutations demonstrated a reduced ability of tau to promote microtubule assembly. Surprisingly, these mutations increased tau's susceptibility to calpain I digestion, suggesting that this feature may be related to the formation of a Pick type of histology. Moreover, these data suggest that Pick's disease is not a separate entity but part of the frontotemporal dementia disease spectrum.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11117542

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  31 in total

Review 1.  Frontotemporal dementia and tauopathy.

Authors:  Y Yoshiyama; V M Lee; J Q Trojanowski
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

Review 2.  Psychogenomics: opportunities for understanding addiction.

Authors:  E J Nestler
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

3.  A Novel Tau Mutation in Exon 12, p.Q336H, Causes Hereditary Pick Disease.

Authors:  Pawel Tacik; Michael DeTure; Kelly M Hinkle; Wen-Lang Lin; Monica Sanchez-Contreras; Yari Carlomagno; Otto Pedraza; Rosa Rademakers; Owen A Ross; Zbigniew K Wszolek; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2015-11       Impact factor: 3.685

4.  PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.

Authors:  Payal Ray; Amar Kar; Kazuo Fushimi; Necat Havlioglu; Xiaoping Chen; Jane Y Wu
Journal:  J Mol Neurosci       Date:  2011-09-01       Impact factor: 3.444

5.  Case records of the Massachusetts General Hospital. Case 9-2015. A 31-year-old man with personality changes and progressive neurologic decline.

Authors:  Bruce L Miller; Bradford C Dickerson; Diane E Lucente; Mykol Larvie; Matthew P Frosch
Journal:  N Engl J Med       Date:  2015-03-19       Impact factor: 91.245

6.  FTDP-17 with Pick body-like inclusions associated with a novel tau mutation, p.E372G.

Authors:  Pawel Tacik; Michael A DeTure; Yari Carlomagno; Wen-Lang Lin; Melissa E Murray; Matthew C Baker; Keith A Josephs; Bradley F Boeve; Zbigniew K Wszolek; Neill R Graff-Radford; Joseph E Parisi; Leonard Petrucelli; Rosa Rademakers; Richard S Isaacson; Kenneth M Heilman; Ronald C Petersen; Dennis W Dickson; Naomi Kouri
Journal:  Brain Pathol       Date:  2016-10-05       Impact factor: 6.508

7.  Slow vertical saccades in the frontotemporal dementia with motor neuron disease.

Authors:  S Y Moon; B H Lee; S W Seo; S J Kang; D L Na
Journal:  J Neurol       Date:  2008-09-25       Impact factor: 4.849

8.  Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure.

Authors:  John Berriman; Louise C Serpell; Keith A Oberg; Anthony L Fink; Michel Goedert; R Anthony Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

Review 9.  Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.

Authors:  Jianhua Zhou; Qingming Yu; Tie Zou
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

Review 10.  Chaperone signalling complexes in Alzheimer's disease.

Authors:  John Koren; Umesh K Jinwal; Daniel C Lee; Jeffrey R Jones; Cody L Shults; Amelia G Johnson; Laura J Anderson; Chad A Dickey
Journal:  J Cell Mol Med       Date:  2009-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.